The co-expression of melanocytic markers, particularly HMB-45, is a hallmark of PEComas and is essential for distinguishing them from other tumors [4], especially PNETs, which are positive for neuroendocrine markers like chromogranin A and synaptophysin. This evidence concerns the gene PMEL and neoplasm with perivascular epithelioid cell differentiation.